|
1
|
Demetriou AA: Support of the acutely
failing liver: State of the art. Ann Surg. 228:14–15. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Leventhal TM and Liu KD: What a
nephrologist needs to know about acute liver failure. Adv Chronic
Kidney Dis. 22:376–381. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bernal W, Hyyrylainen A, Gera A,
Audimoolam VK, McPhail MJ, Auzinger G, Rela M, Heaton N, O'Grady
JG, Wendon J and Williams R: Lessons from look-back in acute liver
failure? A single centre experience of 3300 patients. J Hepatol.
59:74–80. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hu X, Yang T, Li C, Zhang L, Li M, Huang W
and Zhou P: Human fetal hepatocyte line, L-02, exhibits good liver
function in vitro and in an acute liver failure model. Transplant
Proc. 45:695–700. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Guoliang L, Anye Z, Lifu Z, Xiaoping P,
Yimin Z, Chengbo Y, Yuemei C and Lanjuan L: Effects of plasma from
acute-on-chronic liver failure patients on immortalized human
hepatocytes in vitro. Hepatogastroenterology. 58:1328–1333. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Punzalan CS and Barry CT: Acute liver
failure: Diagnosis and management. J Intensive Care Med.
31:642–653. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li Y, Wu Q, Wang Y, Weng C, He Y, Gao M,
Yang G, Li L, Chen F, Shi Y, et al: Novel spheroid reservoir
bioartificial liver improves survival of nonhuman primates in a
toxin-induced model of acute liver failure. Theranostics.
8:5562–5574. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Filippi C, Keatch SA, Rangar D, Nelson LJ,
Hayes PC and Plevris JN: Improvement of C3A cell metabolism for
usage in bioartificial liver support systems. J Hepatol.
41:599–605. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bonavita AG, Quaresma K, Cotta-de-Almeida
V, Pinto MA, Saraiva RM and Alves LA: Hepatocyte
xenotransplantation for treating liver disease.
Xenotransplantation. 17:181–187. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Demetriou AA, Brown RS Jr, Busuttil RW,
Fair J, McGuire BM, Rosenthal P, Am Esch JS II, Lerut J, Nyberg SL,
Salizzoni M, et al: Prospective, randomized, multicenter,
controlled trial of a bioartificial liver in treating acute liver
failure. Ann Surg. 239:660–670. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shi XL, Han B, Tan JJ, Yuan X, Zhang Y,
Xiao JQ, Gu ZZ and Ding YT: Factors influencing the transfer of
porcine endogenous retroviruses across the membrane in
bioartificial livers. Int J Artif Organs. 35:385–391. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Farges O, Ferreira N, Dokmak S, Belghiti
J, Bedossa P and Paradis V: Changing trends in malignant
transformation of hepatocellular adenoma. Gut. 60:85–89. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gouw AS, Zeng W, Buiskool M, Platteel I,
van den Heuvel MC, Poppema S, de Jong KP and Molema G: Molecular
characterization of the vascular features of focal nodular
hyperplasia and hepatocellular adenoma: A role for angiopoietin-1.
Hepatology. 52:540–549. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ji C, Annabi N, Khademhosseini A and
Dehghani F: Fabrication of porous chitosan scaffolds for soft
tissue engineering using dense gas CO2. Acta Biomater. 7:1653–1664.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kunstman JW, Korah R, Healy JM, Prasad M
and Carling T: Quantitative assessment of RASSF1A methylation as a
putative molecular marker in papillary thyroid carcinoma. Surgery.
154:1255–1262. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Selden C, Chalmers SA, Jones C, Standish
R, Quaglia A, Rolando N, Burroughs AK, Rolles K, Dhillon A and
Hodgson HJ: Epithelial colonies cultured from human explanted liver
in subacute hepatic failure exhibit hepatocyte, biliary epithelial,
and stem cell phenotypic markers. Stem Cells. 21:624–631. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tonorezos ES, Barnea D, Abou-Alfa GK,
Bromberg J, D'Angelica M, Sklar CA, Shia J and Oeffinger KC:
Hepatocellular adenoma among adult survivors of childhood and young
adult cancer. Pediatr Blood Cancer. 64:e262942017. View Article : Google Scholar
|
|
19
|
Vijay A, Elaffandi A and Khalaf H:
Hepatocellular adenoma: An update. World J Hepatol. 7:2603–2609.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lee SY, Kim HJ and Choi D: Cell sources,
liver support systems and liver tissue engineering: Alternatives to
liver transplantation. Int J Stem Cells. 8:36–47. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kandiah PA and Subramanian RM:
Extracorporeal devices. Crit Care Clin. 35:135–150. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Khanna M, Ramanathan S, Fasih N, Schieda
N, Virmani V and McInnes MD: Current updates on the molecular
genetics and magnetic resonance imaging of focal nodular
hyperplasia and hepatocellular adenoma. Insights Imaging.
6:347–362. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ellis AJ, Hughes RD, Wendon JA, Dunne J,
Langley PG, Kelly JH, Gislason GT, Sussman NL and Williams R:
Pilot-controlled trial of the extracorporeal liver assist device in
acute liver failure. Hepatology. 24:1446–1451. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chamuleau RA, Deurholt T and Hoekstra R:
Which are the right cells to be used in a bioartificial liver?
Metab Brain Dis. 20:327–335. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hoekstra R and Chamuleau RA: Recent
developments on human cell lines for the bioartificial liver. Int J
Artif Organs. 25:182–191. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hoekstra R, Nibourg GA, van der Hoeven TV,
Ackermans MT, Hakvoort TB, van Gulik TM, Lamers WH, Elferink RP and
Chamuleau RA: The HepaRG cell line is suitable for bioartificial
liver application. Int J Biochem Cell Biol. 43:1483–1489. 2011.
View Article : Google Scholar : PubMed/NCBI
|
